Tech Company Financing Transactions
Geneticure Funding Round
Geneticure, based in Rochester, secured $1 million from Xcellerant Ventures.
Transaction Overview
Company Name
Announced On
10/21/2026
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate its commercial scaling, support a new clinical laboratory in Arizona, and advance its clinical validation.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4 3rd Street Southwest 305B
Rochester, MN 55902
USA
Rochester, MN 55902
USA
Phone
Website
Email Address
Overview
The platform to reliably control the world's #1 preventable cause of death. A single cheek swab guides how high blood pressure is best treated: whether renal denervation will work, and if it is the more traditional route of medications, which one is best for each patient.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Snyder
Chief Medical Officer
Tim Curry
Chief Operating Officer
Eric Snyder
Chief Scientific Officer
Ryan Sprissler
VP - Bus. Development
David Herbert
Browse more venture capital transactions:
Prev: 10/21/2026: Peak Energy venture capital transaction
Next: 10/21/2026: Qualitate venture capital transaction
Share this article
News on VC Transactions
We do our best to document funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs